Search Results - "Luyten, G"

CT and MR imaging of orbital inflammation by Ferreira, Teresa A., Saraiva, P., Genders, S. W., Buchem, M. V., Luyten, G. P. M., Beenakker, J-W

“…Purpose Orbital inflammation can be idiopathic or in the context of a specific disease and it can involve different anatomical orbital structures. On imaging,…”
Get full text

Three‐dimensional MRI‐based treatment planning approach for non‐invasive ocular proton therapy by Fleury, E., Trnková, P., Erdal, E., Hassan, M., Stoel, B., Jaarma‐Coes, M., Luyten, G., Herault, J., Webb, A., Beenakker, J.‐W., Pignol, J.‐P., Hoogeman, M.

“…Purpose To develop a high‐resolution three‐dimensional (3D) magnetic resonance imaging (MRI)‐based treatment planning approach for uveal melanomas (UM) in…”
Get full text

Biocompatibility of a fish scale-derived artificial cornea: Cytotoxicity, cellular adhesion and phenotype, and in vivo immunogenicity by van Essen, T.H, van Zijl, L, Possemiers, T, Mulder, A.A, Zwart, S.J, Chou, C.-H, Lin, C.C, Lai, H.J, Luyten, G.P.M, Tassignon, M.J, Zakaria, N, El Ghalbzouri, A, Jager, M.J

“…Abstract Purpose To determine whether a fish scale-derived collagen matrix (FSCM) meets the basic criteria to serve as an artificial cornea, as determined with…”
Get full text

High-resolution MRI of uveal melanoma using a microcoil phased array at 7 T by Beenakker, J. W. M., van Rijn, G. A., Luyten, G. P. M., Webb, A. G.

“…High‐field MRI is a promising technique for the characterisation of ocular tumours, both in vivo and after enucleation. For in vivo imaging at 7 T, a dedicated…”
Get full text

Reaction on "Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma" by Jaarsma-Coes, M G, Ferreira, T A, Luyten, G P M, Beenakker, J W M

“…In the recently published article entitled "Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma"…”
Get full text

The genetic basis of uveal melanoma by Nielsen, M., Dogrusöz, M., Bleeker, J.C., Kroes, W.G., van Asperen, C.A., Marinkovic, M., Luyten, G.P.M., Jager, M.J.

“…Uveal melanoma (UM) is the most common intraocular malignancy in adults with an incidence of about 1/100,000 new cases per year in the Western world. Risk…”
Get full text

Episodic Src activation in uveal melanoma revealed by kinase activity profiling by Maat, W, Filali, M el, Mulder, A Dirks, Luyten, G P M, Gruis, N A, Desjardins, L, Boender, P, Jager, M J, van der Velden, P A

“…Background: The RAS/RAF/MEK/ERK pathway is involved in the balance between melanocyte proliferation and differentiation. The same pathway is constitutively…”
Get full text

Complications due to bovine pericardium used to cover acrylic implants after enucleation and tubes of aqueous devices by De Vries, F R, Notting, I C, Marinkovic, M, Schalij-Delfos, N E, Luyten, G P M

Get full text

A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors by PLANTING, A. S. T, SONNEVELD, P, PAUL, E. M, PURVIS, N. B, VERWEIJ, J, VAN DER GAAST, A, SPARREBOOM, A, VAN DER BURG, M. E. L, LUYTEN, G. P. M, DE LEEUW, K, DE BOER-DENNERT, M, WISSEL, P. S, JEWELL, R. C

“…Resistance to chemotherapy can partly be explained by the activity of membrane bound P-glycoprotein. Competitive inhibition of P-glycoprotein, by multidrug…”
Get full text

Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification by Hes, FJ, van der Luijt, RB, Janssen, ALW, Zewald, RA, de Jong, GJ, Lenders, JW, Links, TP, Luyten, GPM, Sijmons, RH, Eussen, HJ, Halley, DJJ, Lips, CJM, Pearson, PL, van den Ouweland, AMW, Majoor-Krakauer, DF

“…The current clinical diagnosis of Von Hippel‐Lindau (VHL) disease demands at least one specific a sporadic VHL manifestation in a patient with familial VHL…”
Get full text

Retained intraocular foreign body masquerading as malignant melanoma of the iris by Maat, W., Missotten, G. S., Luyten, G. P. M., de Keizer, R. J. W.

Get full text

Phase I and Pharmacokinetic Study of the Oral Farnesyl Transferase Inhibitor SCH 66336 Given Twice Daily to Patients With Advanced Solid Tumors by ESKENS, Ferry A. L. M, AWADA, Ahmad, PICCART, Martine, CUTLER, David L, DE JONGE, Maja J. A, LUYTEN, Gré P. M, FABER, Marije N, STATKEVICH, Paul, SPARREBOOM, Alex, VERWEIJ, Jaap, HANAUSKE, Axel-R

“…A single-agent dose-escalating phase I and pharmacokinetic study on the farnesyl transferase inhibitor SCH 66336 was performed to determine the safety profile,…”
Get full text

Iris-claw phakic intraocular lens for high myopia by Landesz, M, van Rij, G, Luyten, G

“…To evaluate the efficacy, safety, predictability, and stability of implanting a polymethylmethacrylate (PMMA) phakic intraocular lens (PIOL) (the Artisan…”
Get more information

Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma by Blom, DJ, Luyten, GP, Mooy, C, Kerkvliet, S, Zwinderman, AH, Jager, MJ

“…Because the expression of human leukocyte antigen (HLA) antigens is important for immunologic recognition of tumor cells, we determined expression of…”
Get full text

Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model by Ma, D, Luyten, GP, Luider, TM, Niederkorn, JY

“…The purpose of this study was to determine the susceptibility of human uveal melanoma cells to in vitro and in vivo natural killer (NK) cell-mediated cytolysis…”
Get full text

Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma by Mooy, CM, Luyten, GP, de Jong, PT, Luider, TM, Stijnen, T, van de Ham, F, van Vroonhoven, CC, Bosman, FT

“…Neoplasia can be defined as deregulated tissue homeostasis caused by an imbalance between proliferation and apoptosis. Many genes are involved in the…”
Get full text

Establishment and characterization of primary and metastatic uveal melanoma cell lines by Luyten, Gregorius P. M., Naus, Nicole C., Mooy, Cornelia M., Hagemeijer, Anne, Kan‐Mitchell, June, Van Drunen, Ellen, Vuzevski, Vojislav, De Jong, Paulus T. V. M., Luider, Theo M.

“…We report on the establishment and characterization of 2 primary (EOM‐3, EOM‐29) and 3 metastatic uveal melanoma cell lines (OMM‐1, OMM‐2, OMM‐3), and further…”
Get full text

PD-0075 3D MRI versus conventional ultrasound tumour measurements for treatment planning of eye tumours by Klaassen, L., Jaarsma-Coes, M., Ferreira, T., Vu, K., Marinkovic, M., Luyten, G., Rasch, C., Beenakker, J.

Get full text

PO-1429 First results of the Leiden-Holland Proton Therapy Center collaboration for uveal melanoma treatment by Horeweg, N., Verbeek, E., Vu, K., Marinkovic, M., Bleeker, J., Rodrigues, M., Klaver, Y., Beenakker, J., Luyten, G., Rasch, C.

Get full text

PO-1587 two years of ocular proton therapy in The Netherlands, clinical results by Rasch, C., Bakker, P., Rodrigues, M., Marinkovic, M., Vu, K., Bleeker, J., van Rij, C., Kilic, E., Beenakker, J., Horeweg, N., Luyten, G.

Get full text